SEC Form 3 filed by new insider Accel Growth Fund Iv L.P.

1/28/26 8:48:16 PM ET

$LIFE

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Get the next $LIFE alert in real time by email

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Accel Growth Fund IV L.P.

(Last)

(First)

(Middle)

500 UNIVERSITY AVENUE

(Street)

PALO ALTO

94301

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/28/2026

3. Issuer Name and Ticker or Trading Symbol
Ethos Technologies Inc. [ LIFE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series B Preferred Stock	⁽¹⁾	⁽²⁾	Class A Common Stock	5,602,701	⁽¹⁾	D
Series C Preferred Stock	⁽¹⁾	⁽²⁾	Class A Common Stock	988,276	⁽¹⁾	D
Series D Preferred Stock	⁽¹⁾	⁽²⁾	Class A Common Stock	189,998	⁽¹⁾	D
Series B Preferred Stock	⁽¹⁾	⁽²⁾	Class A Common Stock	267,983	⁽¹⁾	I	By Accel Growth Fund Investors 2016 L.L.C.
Series C Preferred Stock	⁽¹⁾	⁽²⁾	Class A Common Stock	47,268	⁽¹⁾	I	By Accel Growth Fund Investors 2016 L.L.C.
Series D Preferred Stock	⁽¹⁾	⁽²⁾	Class A Common Stock	9,087	⁽¹⁾	I	By Accel Growth Fund Investors 2016 L.L.C.
Series B Preferred Stock	⁽¹⁾	⁽²⁾	Class A Common Stock	31,871	⁽¹⁾	I	By Accel Growth Fund IV L.P. Strategic Partners L.P.
Series C Preferred Stock	⁽¹⁾	⁽²⁾	Class A Common Stock	5,622	⁽¹⁾	I	By Accel Growth Fund IV L.P. Strategic Partners L.P.
Series D Preferred Stock	⁽¹⁾	⁽²⁾	Class A Common Stock	1,080	⁽¹⁾	I	By Accel Growth Fund IV L.P. Strategic Partners L.P.

1. Name and Address of Reporting Person^*

Accel Growth Fund IV L.P.

(Last)

(First)

(Middle)

500 UNIVERSITY AVENUE

(Street)

PALO ALTO

94301

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Accel Growth Fund Investors 2016 L.L.C.

(Last)

(First)

(Middle)

500 UNIVERSITY AVENUE

(Street)

PALO ALTO

94301

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Accel Growth Fund IV Strategic Partners L.P.

(Last)

(First)

(Middle)

500 UNIVERSITY AVENUE

(Street)

PALO ALTO

94301

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Accel Growth Fund IV Associates L.L.C.

(Last)

(First)

(Middle)

500 UNIVERSITY AVENUE

(Street)

PALO ALTO

94301

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

1. The Series B, Series C, and Series D Preferred Stock are each convertible into Class A Common Stock on a ratio dependent on the public offering price of the Class A Common Stock in the Issuer's initial public offering, and have no expiration date. Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock will be automatically converted into shares of Class A Common Stock of the Issuer (the "Class A Conversion"). Immediately following the Class A Conversion, each share of Class A Common Stock shall be exchanged at a 1:1 ratio for shares of Class B Common Stock.

2. Each share of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock has no expiration date.

	/s/ Jaspreet Singh, Attorney-in-Fact on behalf Accel Growth Fund IV Strategic Partners L.P.	01/28/2026
	/s/ Jaspreet Singh, Attorney-in-Fact on behalf of Accel Growth Fund IV L.P.	01/28/2026
	/s/ Jaspreet Singh, Attorney-in-Fact on behalf of Accel Growth Fund Investors 2016 L.L.C.	01/28/2026
	/s/ Jaspreet Singh, Attorney-in-Fact on behalf of Accel Growth Fund IV Associates L.L.C.	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $LIFE alert in real time by email

Recent Analyst Ratings for

$LIFE

Date	Price Target	Rating	Analyst
7/5/2023		Outperform → Perform	Oppenheimer
11/11/2021	$18.00 → $11.00	Buy	HC Wainwright & Co.
11/11/2021	$18.00 → $11.00	Action List Buy	HC Wainwright & Co.
10/12/2021	$22.00	Outperform	RBC Capital
9/21/2021	$19.00	Overweight	Piper Sandler
9/14/2021	$20.00 → $21.00	Buy	Roth Capital
9/14/2021	$14.00 → $20.00	Outperform	Oppenheimer
9/13/2021	$13.00 → $18.00	Buy	HC Wainwright & Co.

More analyst ratings

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr. 4)

2. Amount of Securities Beneficially Owned (Instr. 4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)

4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)

2. Date Exercisable and Expiration Date (Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)

6. Nature of Indirect Beneficial Ownership (Instr. 5)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Series B Preferred Stock

⁽¹⁾

⁽²⁾

Class A Common Stock

5,602,701

⁽¹⁾

Series C Preferred Stock

⁽¹⁾

⁽²⁾

Class A Common Stock

988,276

⁽¹⁾

Series D Preferred Stock

⁽¹⁾

⁽²⁾

Class A Common Stock

189,998

⁽¹⁾

Series B Preferred Stock

⁽¹⁾

⁽²⁾

Class A Common Stock

267,983

⁽¹⁾

By Accel Growth Fund Investors 2016 L.L.C.

Series C Preferred Stock

⁽¹⁾

⁽²⁾

Class A Common Stock

47,268

⁽¹⁾

By Accel Growth Fund Investors 2016 L.L.C.

Series D Preferred Stock

⁽¹⁾

⁽²⁾

Class A Common Stock

9,087

⁽¹⁾

By Accel Growth Fund Investors 2016 L.L.C.

Series B Preferred Stock

⁽¹⁾

⁽²⁾

Class A Common Stock

31,871

⁽¹⁾

By Accel Growth Fund IV L.P. Strategic Partners L.P.

Series C Preferred Stock

⁽¹⁾

⁽²⁾

Class A Common Stock

5,622

⁽¹⁾

By Accel Growth Fund IV L.P. Strategic Partners L.P.

Series D Preferred Stock

⁽¹⁾

⁽²⁾

Class A Common Stock

1,080

⁽¹⁾

By Accel Growth Fund IV L.P. Strategic Partners L.P.

Recent Analyst Ratings for

$LIFE

Date	Price Target	Rating	Analyst
7/5/2023		Outperform → Perform	Oppenheimer
11/11/2021	$18.00 → $11.00	Buy	HC Wainwright & Co.
11/11/2021	$18.00 → $11.00	Action List Buy	HC Wainwright & Co.
10/12/2021	$22.00	Outperform	RBC Capital
9/21/2021	$19.00	Overweight	Piper Sandler
9/14/2021	$20.00 → $21.00	Buy	Roth Capital
9/14/2021	$14.00 → $20.00	Outperform	Oppenheimer
9/13/2021	$13.00 → $18.00	Buy	HC Wainwright & Co.

More analyst ratings

SEC Form 3 filed by new insider Accel Growth Fund Iv L.P.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$LIFE

SEC Form 3 filed by new insider Accel Growth Fund Iv L.P.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$LIFE

$LIFE
Insider Trading